Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaycha Group is a private U.S. cannabis testing and analytics company operating a multi-state network of ISO 17025-accredited laboratories under the Kaycha Labs brand. The company provides analytical testing services for cultivators, processors, manufacturers, and dispensaries in regulated cannabis and hemp markets, including potency, terpene, pesticide, heavy metal, microbial, mycotoxin, and residual solvent testing. Kaycha also emphasizes proprietary laboratory software through its PureLIMS platform for sample tracking, workflow automation, reporting, and certificate-of-analysis delivery. The business is not a drug developer; it is a commercial laboratory and compliance infrastructure provider serving the cannabis industry. Its operations appear concentrated in the United States, with headquarters in Miramar, Florida.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaycha Group.